“Clinical Safety and Pharmacokinetics of FMX101 4% Topical Minocycline Foam in Pediatric Patients for the Treatment of Moderate-to-Severe Acne Vulgaris”, J of Skin, vol. 3, p. S2, Nov. 2019, doi: 10.25251/skin.3.supp.2.